For example: If you start on a lower dose of Semaglutide or Tirzepatide, say 0.25 mg, you might increase the dose to 0.5 mg after a week
2 La incidencia de eventos fue muy baja en los grupos GLP-1 de AR (0,047 por cada 100 personas-ao) y placebo (0,042 por cada 100 personas-ao), sin diferencias estadsticamente significativas (riesgo relativo, 0,76
Dual Mechanism : The combination of GLP-1 and GIP receptor activation may provide a more extensive approach to glucose control and appetite suppression
Prior studies also showed a delayed time to relapse versus placebo
Li L, Clevers H
For obesity management, NICE technology appraisal TA875 recommends semaglutide (Wegovy) only within specialist weight management services, for people with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities) and as part of a programme including diet and physical activity for a maximum of 2 years